Like other diseases, risk factors for breast cancer can be divided into those that are modifiable (those that a person may change through behavioral modification) and non-modifiable (those that a person cannot normally change).

 

Below are a list of risk factors according to the American Cancer Society.

 

 

Non-modifiable Risk Factors include:

 

Gender
A major risk factor for developing breast cancer is simply being a woman. Men can develop breast cancer (approximately 1,910 cases of male breast cancer are expected in 2009), but the disease is about 100 times more common among women.

 

Aging
The risk of developing breast cancer increases as a woman ages. A woman’s overall lifetime risk of developing breast cancer is about 12% (1 in 8).

 

Genetic risk factors
About 5% to 10% of breast cancer cases are thought to be hereditary, resulting directly from gene changes (called mutations) inherited from a parent. There are several gene mutations that have been associated with an increased breast cancer risk.

 

BRCA1 and BRCA2:
In a person without this gene mutation, these genes act as tumor suppressors, producing proteins meant to prevent abnormal cell growth. When the gene is mutated, they are no longer able to function as tumor suppressors, so breast cancer is more likely to develop. Although mutations to these genes are relatively rare (less than 1% of the population), they can significantly increase risk if present. Women with an inherited BRCA1 or BRCA2 mutation have up to an 80% chance of developing breast cancer during their lifetime, and when they do it is often at a younger age than in women who are not born with one of these gene mutations. Women with these inherited mutations also have an increased risk for developing ovarian cancer.

Changes in other genes: Other gene changes might also lead to inherited breast cancers. These genes do not pass on the same level of breast cancer risk as the BRCA genes, and do not frequently cause familial or inherited breast cancer.

 

• ATM: The ATM gene normally helps repair damaged DNA. Certain families with a high rate of breast cancer have been found to have mutations of this gene.

• CHEK2: The CHEK2 gene increases breast cancer risk about two-fold when mutated. In women who carry the CHEK2 mutation and have a strong family history of breast cancer, the risk is greatly increased.

• p53: Inherited mutations of the p53 tumor suppressor gene can also increase the risk of developing breast cancer, as well as several other cancers such as leukemia, brain tumors, and sarcomas (cancer of bones or connective tissue).

• The Li-Fraumeni syndrome, named after the 2 researchers who first described this inherited cancer syndrome, is a rare cause of breast cancer. It develops if a person inherits only one functional copy of the p53 gene from their parents. Persons with this syndrome are at risk for a wide range of malignancies, with particularly high occurrences of breast cancer, brain tumors, acute leukemia, soft tissue sarcomas, bone sarcomas, and adrenal cortical carcinoma.

• PTEN: The PTEN gene normally helps regulate cell growth. Inherited mutations in this gene cause Cowden syndrome, a rare disorder in which people are at increased risk for both benign and malignant breast tumors, as well as growths in the digestive tract, thyroid, uterus, and ovaries.

 

Genetic testing can be done to look for mutations in the BRCA1 and BRCA2 genes (or less commonly in other genes such as PTEN or p53).

 

Family history of breast cancer
Breast cancer risk is higher among women whose close blood relatives have this disease.

 

Having one first-degree relative (mother, sister, or daughter) with breast cancer approximately doubles a woman's risk. Having 2 first-degree relatives increases her risk about 5-fold.

 

Although the exact risk is not known, women with a family history of breast cancer in a father or brother also have an increased risk of breast cancer. Altogether, about 20% to 30% of women with breast cancer have a family member with this disease.

 

It’s important to note this means that 70% to 80% of women who get breast cancer DO NOT have a family history of this disease.

 

A woman with cancer in one breast has a 3- to 4-fold increased risk of developing
Personal history of breast cancerthe first cancer.a new cancer in the other breast or in another part of the same breast. This is different from a recurrence (return) of the first cancer.

 

Race and ethnicity
White women are slightly more likely to develop breast cancer than are African-American women. African-American women are more likely to die of this cancer. At least part of this seems to be because African-American women tend to have more aggressive tumors, although why this is the case is not known. Asian, Hispanic, and Native-American women have a lower risk of developing and dying from breast cancer.

Dense breast tissue

Breast density, a measure of glandular tissue, fatty tissue, is also a risk factor for breast cancer. Women with the highest levels of density have a 4- to 6-times increased risk of developing breast cancer. Dense breast tissue can also make it harder for doctors to spot problems on mammograms.

 

Certain benign breast conditions
Women diagnosed with certain benign breast conditions may have an increased risk of breast cancer. Some of these conditions are more closely linked to breast cancer risk than others. Doctors often divide benign breast conditions into 3 general groups, depending on how they affect this risk.

 

Non-proliferative lesions: These conditions are not associated with overgrowth of breast tissue). They do not seem to affect breast cancer risk, or if they do, it is to a very small extent. They include:

• fibrocystic disease (fibrosis and/or cysts)

• mild hyperplasia (an abnormal overgrowth of cells)

• adenosis (non-sclerosing, or non-hardening of tissue)

• simple fibroadenoma

• phyllodes tumor (benign)

• a single papilloma

• fat necrosis

• mastitis

• duct ectasia

• other benign tumors (lipoma, hamartoma, hemangioma, neurofibroma)

 

Proliferative lesions without atypia: These show excessive growth of cells in the ducts or lobules of the breast tissue. They seem to raise a woman's risk of breast cancer slightly (1 1/2 to 2 times normal). They include:

• usual ductal hyperplasia (without atypia)

• complex fibroadenoma

• sclerosing adenosis

• several papillomas or papillomatosis

• radial scar

 

Proliferative lesions with atypia: In these conditions, there is excessive growth of cells in the ducts or lobules of the breast tissue, and the cells no longer appear normal. They have a stronger effect on breast cancer risk, raising it 4 to 5 times higher than normal. They include:

• atypical ductal hyperplasia (ADH)

• atypical lobular hyperplasia (ALH)

 

Women with a family history of breast cancer and either hyperplasia or atypical hyperplasia have an even higher risk of developing a breast cancer.

 

Menstrual periods 
Women who have had more menstrual cycles because they started menstruating at an early age (before age 12) and/or went through menopause at a later age (after age 55) have a slightly higher risk of breast cancer. This may be related to a higher lifetime exposure to the hormones estrogen and progesterone.

 

Previous chest radiation 

Women who, as children or young adults, had radiation therapy to the chest area as treatment for another cancer (such as Hodgkin disease or non-Hodgkin lymphoma) are at significantly increased risk for breast cancer. This varies with the patient's age when they had radiation. If chemotherapy was also given, the risk may be lowered if the chemotherapy stopped ovarian hormone production. The risk of developing breast cancer appears to be highest if the radiation was given during adolescence, when the breasts were still developing.

 

Diethylstilbestrol exposure
From the 1940s through the 1960s some pregnant women were given the drug diethylstilbestrol (DES) because it was thought to lower their chances of losing the baby (miscarriage). These women have a slightly increased risk of developing breast cancer. Women whose mothers took DES during pregnancy may also have a slightly higher risk of breast cancer.

 

Modifiable factors and breast cancer risk

 

Not having children, or having them later in life
Women who have had no children or who had their first child after age 30 have a slightly higher breast cancer risk. Having many pregnancies and becoming pregnant at an early age reduces breast cancer risk. Pregnancy reduces a woman's total number of lifetime menstrual cycles, which may be the reason for this effect.

Studies have found that women using oral contraceptives (birth control pills) have a slightly greater risk of breast cancer than women who have never used them, but this risk seems to decline once their use is stopped. Women who stopped using oral contraceptives more than 10 years ago do not appear to have any increased breast cancer risk. When thinking about using oral contraceptives, women should discuss their other risk factors for breast cancer with ther health care team.

Recent oral contraceptive use

Post-menopausal hormone therapy (PHT), also known as hormone replacement therapy (HRT), has been used for many years to help relieve symptoms of menopause and to help prevent osteoporosis (thinning of the bones). Earlier studies suggested it might have other health benefits as well, but more recent
Using post-menopausal hormone therapybetter designed studies have not found them.,

There are 2 main types of PHT. For women who still have a uterus (womb), doctors generally prescribe estrogen and progesterone (known as combined PHT). Because estrogen alone can increase the risk of cancer of the uterus, progesterone is added to help prevent this. For women who no longer have a uterus (those who've had a hysterectomy), estrogen alone can be prescribed. This is commonly known as estrogen replacement therapy (ERT).

 

Combined PHT: Long-term use (several years or more) of combined post-menopausal hormone therapy increases the risk of breast cancer and may also increase the chances of dying of breast cancer. Large studies have found that there is an increased risk of breast cancer related to the use of combined PHT. Combined PHT also increases the likelihood that the cancer may be found at a more advanced stage, possibly because it reduces the effectiveness of mammograms.

 

The increased risk from combined PHT appears to apply only to current and recent users. A woman's breast cancer risk seems to return to that of the general population within 5 years of stopping combined PHT.

 

ERT: The use of estrogen alone does not appear to increase the risk of developing breast cancer significantly, if at all. But when used long term (for more than 10 years), ERT has been found to increase the risk of ovarian and breast cancer in some studies.

 

At this time there appear to be few strong reasons to use post-menopausal hormone therapy (combined PHT or ERT), other than possibly for the short-term relief of menopausal symptoms. Along with the increased risk of breast cancer, combined PHT also appears to increase the risk of heart disease, blood clots, and strokes. It does lower the risk of colorectal cancer and osteoporosis, but this must be weighed against the possible harm, and it should be noted that there are other effective ways to prevent osteoporosis. Although ERT does not seem to have much effect on breast cancer risk, it does increase the risk of stroke.

 

The decision to use PHT should be made by a woman and her doctor after weighing the possible risks and benefits (including the severity of her menopausal symptoms), and considering her other risk factors for heart disease, breast cancer, and osteoporosis. If a woman and her doctor decide to try PHT for symptoms of menopause, it is usually best to use it at the lowest dose that works for her and for as short a time as possible.

 

Not breast-feeding

Some studies suggest that breast-feeding may slightly lower breast cancer risk, especially if breast-feeding is continued for 1 1/2 to 2 years. But this has been a difficult area to study, especially in countries such as the United States, where breast-feeding for this long is uncommon.

 

The explanation for this possible effect may be that breast-feeding reduces a woman's total number of lifetime menstrual cycles (similar to starting menstrual periods at a later age or going through early menopause).

 

Alcohol
Use of alcohol is clearly linked to an increased risk of developing breast cancer. The risk increases with the amount of alcohol consumed. Compared with non-drinkers, women who consume 1 alcoholic drink a day have a very small increase in risk. Those who have 2 to 5 drinks daily have about 1 1/2 times the risk of women who drink no alcohol. Excessive alcohol use is also known to increase the risk of developing cancers of the mouth, throat, esophagus, and liver. The American Cancer Society recommends that women limit their consumption of alcohol to no more than one drink per day.

 

Being overweight or obese

Being overweight or obese has been found to increase breast cancer risk, especially for women after menopause. Before menopause your ovaries produce most of your estrogen, and fat tissue produces a small amount of estrogen. After menopause (when the ovaries stop making estrogen), most of a woman's estrogen comes from fat tissue. Having more fat tissue after menopause can increase your estrogen levels and thereby increase your likelihood of developing breast cancer.

 

The connection between weight and breast cancer risk is complex, however. For example, the risk appears to be increased for women who gained weight as an adult but may not be increased among those who have been overweight since childhood. Also, excess fat in the waist area may affect risk more than the same amount of fat in the hips and thighs. Researchers believe that fat cells in various parts of the body have subtle differences that may explain this.

 

The American Cancer Society recommends you maintain a healthy weight throughout your life by balancing your food intake with physical activity and avoiding excessive weight gain.

​

Lack of physical activity 
Evidence is growing that physical activity in the form of exercise reduces breast cancer risk. The only question is how much exercise do you need? In one study from the Women's Health Initiative (WHI) as little as 1.25 to 2.5 hours per week of brisk walking reduced a woman's risk by 18%. Walking 10 hours a week reduced the risk a little more.

 

To reduce your risk of breast cancer, the American Cancer Society recommends 45 to 60 minutes of intentional physical activity 5 or more days a week.

​

Factors with uncertain, controversial, or unproven effect on breast cancer risk

 

High-fat diets
Studies of fat in the diet have not clearly shown that this is a breast cancer risk factor.

 

Most studies have found that breast cancer is less common in countries where the typical diet is low in total fat, low in polyunsaturated fat, and low in saturated fat. On the other hand, many studies of women in the United States have not related breast cancer risk to dietary fat intake. Researchers are still not sure how to explain this apparent disagreement. Studies comparing diet and breast cancer risk in different countries are complicated by other differences (such as activity level, intake of other nutrients, and genetic factors) that might also alter breast cancer risk.

 

More research is needed to better understand the effect of the types of fat eaten on breast cancer risk. But it is clear that calories do count, and fat is a major source of these. High-fat diets can lead to being overweight or obese, which is a breast cancer risk factor. A diet high in fat has also been shown to influence the risk of developing several other types of cancer, and intake of certain types of fat is clearly related to heart disease risk.

 

The American Cancer Society recommends eating a healthy diet with an emphasis on plant sources. This includes eating 5 or more servings of vegetables and fruits each day, choosing whole grains over processed (refined) grains, and limiting consumption of processed and red meats.

 

Antiperspirants
Internet e-mail rumors have suggested that chemicals in underarm antiperspirants are absorbed through the skin, interfere with lymph circulation, cause toxins to build up in the breast, and eventually lead to breast cancer. There is very little laboratory or population-based evidence to support this rumor.

 

One small study has found trace levels of parabens (used as preservatives in antiperspirants and other products), which have weak estrogen-like properties, in a small sample of breast cancer tumors. However, the study did not look at whether parabens caused the tumors. This was a preliminary finding, and more research is needed to determine what effect, if any, parabens may have on breast cancer risk. On the other hand, a large study of breast cancer causes found no increase in breast cancer in women who used underarm antiperspirants or shaved their underarms.

 

Bras
Internet e-mail rumors and at least one book have suggested that bras cause breast cancer by obstructing lymph flow. There is no good scientific or clinical basis for this claim. Women who do not wear bras regularly are more likely to be thinner, which would likely contribute to any perceived difference in risk.

 

Induced abortion
Several studies have provided very strong data that neither induced abortions nor spontaneous abortions (miscarriages) have an overall effect on the risk of breast cancer. For more detailed information, see the separate American Cancer Society document, Can Having an Abortion Cause or Contribute to Breast Cancer?

Breast implants

Several studies have found that breast implants do not increase breast cancer risk, although silicone breast implants can cause scar tissue to form in the breast. Implants make it harder to see breast tissue on standard mammograms, but additional x-ray pictures called implant displacement views can be used to examine the breast tissue more completely.

​

Chemicals in the environment
A great deal of research has been reported and more is being done to understand possible environmental influences on breast cancer risk.

 

Of special interest are compounds in the environment that have been found in lab studies to have estrogen-like properties, which could in theory affect breast cancer risk. For example, substances found in some plastics, certain cosmetics and personal care products, pesticides (such as DDE), and PCBs (polychlorinated biphenyls) seem to have such properties.

 

While this issue understandably invokes a great deal of public concern, at this time research does not show a clear link between breast cancer risk and exposure to these substances. Unfortunately, studying such effects in humans is difficult. More research is needed to better define the possible health effects of these and similar substances.

 

Tobacco smoke
Most studies have found no link between cigarette smoking and breast cancer. Although some studies have suggested smoking increases the risk of breast cancer, this remains controversial.

 

An active focus of research is whether secondhand smoke increases the risk of breast cancer. Both mainstream and secondhand smoke contain chemicals that, in high concentrations, cause breast cancer in rodents. Chemicals in tobacco smoke reach breast tissue and are found in breast milk.

 

The evidence on secondhand smoke and breast cancer risk in human studies is controversial, at least in part because smokers have not been shown to be at increased risk. One possible explanation for this is that tobacco smoke may have different effects on breast cancer risk in smokers and in those who are just exposed to smoke.

A report from the California Environmental Protection Agency in 2005 concluded that the evidence about secondhand smoke and breast cancer is "consistent with a causal association" in younger, mainly pre-menopausal women. The 2006 US Surgeon General's report, The Health Consequences of Involuntary Exposure to Tobacco Smoke, concluded that there is "suggestive but not sufficient" evidence of a link at this point. In any case, this possible link to breast cancer is yet another reason to avoid secondhand smoke.

​

Night work
Several studies have suggested that women who work at night — for example, nurses on a night shift — may have an increased risk of developing breast cancer. This is a fairly recent finding, and more studies are looking at this issue. Some researchers think the effect may be due to changes in levels of melatonin, a hormone whose production is affected by the body's exposure to light, but other hormones are also being studied.